Sisram Medical Ltd
SRAMF
$0.535
$0.5350.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -12.53% | -16.94% | -20.23% | -30.41% | -38.74% |
| Total Depreciation and Amortization | 2.92% | 11.46% | 21.57% | 29.51% | 38.80% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -163.17% | -131.96% | -92.97% | -55.47% | -36.39% |
| Change in Net Operating Assets | -40.93% | -40.93% | -40.93% | 65.52% | 83.30% |
| Cash from Operations | -39.25% | -31.63% | -24.70% | 15.29% | 106.05% |
| Capital Expenditure | 48.40% | 59.41% | 67.92% | 37.65% | -2.58% |
| Sale of Property, Plant, and Equipment | -180.00% | -153.25% | -8.33% | 2,433.33% | 822.22% |
| Cash Acquisitions | 64.47% | 90.52% | 94.53% | 88.69% | 81.80% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -203.77% | -173.47% | -126.90% | 123.08% | 123.66% |
| Cash from Investing | -3,952.62% | 25.50% | 80.01% | 94.77% | 100.54% |
| Total Debt Issued | 334.82% | 215.26% | 70.33% | 37.69% | 8.47% |
| Total Debt Repaid | -163.73% | -94.13% | -22.85% | -18.33% | -13.33% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 10.09% | 10.09% | 10.09% | -0.63% | -12.71% |
| Other Financing Activities | 26.56% | 76.41% | 102.81% | 79.14% | 62.27% |
| Cash from Financing | -0.06% | 12.18% | 23.14% | 13.65% | 3.43% |
| Foreign Exchange rate Adjustments | 165.47% | 118.35% | 80.96% | 49.57% | 16.57% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -154.94% | -111.08% | 167.10% | 127.06% | 120.60% |